ArticleCell death & disease2026

TP53 mutations in triple-negative breast cancer cells confer sensitivity to ASCT2 inhibition via arginine uptake.

Xiaodan Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.